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Primary ﬁbroblasts from a healthy individual H0002 (female,
19 years, no steatosis) were reprogrammed by transduction of retrovi-
ruses encoding for OCT4, SOX2, KLF-4 and c-MYC (Jozefczuk et al.,
2012). The cell line expressed the pluripotency-associated transcription
factors OCT4, NANOG, SOX2 and cell surfacemarkers SSEA-4, TRA-1-60,
TRA-1-81. Pluripotency was further demonstrated in vitro by embryoid
body (EB)-based differentiation to the three germ layers endoderm, ec-
toderm, and mesoderm. DNA ﬁngerprinting conﬁrmed the origin of
both iPSC lines, while karyogram revealed a 46,XX karyotype for the
cell lines CO2.
Materials and methods
Patient recruitment, sample collection and clinical measurements
The study was approved by the institutional review board of the
Medical University of Graz (reg. IRB00002556 at the Ofﬁce for Human
Research Protections of the US Departments of Health and Human Ser-
vices) under license 20–143 ex 08/09. For more details seeWruck et al.,
2015 (Table 1).
Cell culture
Human primary ﬁbroblast cells were cultured in high-glucose
Dulbecco's Modiﬁed Eagle's Medium (DMEM) substitutedwith 1% Pen-
icillin-Streptomycin (Penstrep), 1% Glutamine and 10% fetal calf serum
(FCS) at 37 °C and 5% CO2. IPSCs were cultured in Essential 8 (E8)Medi-
um with 1% Penstrep on Matrigel or mouse embryonic ﬁbroblaststhe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Characterization of theH0012-derived iPSC line S12 The iPSC line S12was characterized using the followingmarkers, OCT4, SOX2 and NANOG (A) and SSEA4, TRA-1-60 and TRA-1-
81 (A). (scale bar: 200 μm). Pluripotency in vitro was conﬁrmed by EB formation (B) and subsequent ICC-based detection of cells representative of the three germ layers- ectodermal
(NESTIN), mesodermal (SMA) and endodermal (SOX17) markers. (scale bar: 100 μm). The Origin of iPSC line S12 was determined via karyotype (C) and DNA-ﬁngerprint (D). DNA
ﬁngerprinting conﬁrmed the origin of the iPSC line via Primers D7S796 (Jozefczuk et al., 2012) and D21S2055 (Matz and Adjaye, 2015), while karyogram detected a 46,XX karyotype.
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replated on a weekly basis.
Derivation of iPSCs
The cell line CO2 was reprogrammed into iPSCs by transduction of
retroviruses encoding for OCT4, SOX2, KLF-4 and c-MYC as described
in Jozefczuk et al. (2012).
DNA ﬁngerprinting analysis
The STR analysis was performed by PCR ampliﬁcation with
the following primer sequences (5′–3): D17S1290 forward
GCAACAGAGCAAGACTGTC, reverse GGAAACAGTTAAATGGCCAA;
and D21S2055 forward AACAGAACCAATAGGCTATCTATC and re-
verse TACAGTAAATCACTTGGTAGGAGA.
Embryoid body formation
EB formation and Immunocytochemistry was performed as
described in Matz and Adjaye (2015). Further differentiation intocells representative of all three germ layers was performed by Immuno-
cytochemistry (ICC). Primary antibodies used are as follows, SMA
(1:100, Cell Signalling Technology®) for mesodermal cells. SOX17
(1:50, R&D Systems) for endodermal cells and Nestin (1:500, Sigma-Al-
drich) for ectodermal differentiation. Nuclear Hoechst (1:5000) was
used for co-staining. Images were captured using a ﬂuorescence micro-
scope (AxioVision).
Immunoﬂuorescence-based detection of pluripotency associated proteins
The following primary antibodies were used, SOX2 (1:400, Cell Sig-
nalling Technology®), OCT4 (1:400, Cell Signalling Technology®),
NANOG (1:800, Cell Signalling Technology®), TRA-1-60 (1:1000, Cell
Signalling Technology®), TRA-1-81 (1:1000, Cell Signalling Technolo-
gy®) and SSEA4, (1:1000, Cell Signalling Technology®). After ﬁxation
of the cells with 4% paraformaldehyde (PFA) and blocking of unspeciﬁc
binding-sites, the primary antibodies were incubated over night at 4 °C.
After several washing steps the secondary antibody incubation (1:500,
anti-mouse-Cy3 (Thermo Fisher Scientiﬁc), anti-mouse-Alexa488
(Thermo Fisher Scientiﬁc), anti-rabbit-Alexa488 (Thermo Fisher Scien-
tiﬁc)) was performed for 1 h at room temperature (RT). Nuclei were
Fig. 2. Microarray-based transcriptome analysis Microarray-based transcriptome analysis Dendrogram of patient's ﬁbroblasts (Fibroblasts), embryonic stem cells (H1_ES) and the
retroviral-derived iPSC line (C02_iPS).
Table 1
Clinical background of donor primary ﬁbroblast cell line.
H0002
Gender F
Age 19
BMI 21
Steatosis NA
Operation mamma reduction
Steatosis grade group non-obese
Waist ND
Hip ND
RR syst/blood pressure ND
T2DM ND
Hypertension ND
ALT ND
AST ND
GGT ND
Fasting glucose ND
Insulin ND
HOMA-IR ND
CHOL ND
TRIG ND
HDL ND
599M.-A. Kawala et al. / Stem Cell Research 17 (2016) 597–599identiﬁed using nuclear Hoechst (1:5000) co-staining and images were
captured by a ﬂuorescence microscope (AxioVision).
Karyotype analysis
Karyotype analysis was evaluated and performed at the Institute of
Human Genetics and Anthropology, Heinrich-Heine-University,
Düsseldorf.Microarray-based transcriptome analysis
Global gene expression analysis was carried out on the Affymetrix
microarray platform. For each sample, 1 μg quality-checked total RNA
were used as input for the ampliﬁcation and biotin labeling reactions,
which precede bead chip hybridizations. RNA hybridizations was car-
ried out by Biologisch-medizinisches Forschungszentrum (BMFZ),
Heinrich-Heine University, Düsseldorf. The correlation values were cal-
culated using the Gene Expression Module of the software R/
Bioconductor (Affymetrix). Correlation coefﬁcient of C02 iPSCs and H1
ESCs is 0.8952.
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